Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Current Assets: 2012-2024

Historic Current Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Dec 2024 value amounting to $965.6 million.

  • Agios Pharmaceuticals' Current Assets fell 3.82% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 3.82%. This contributed to the annual value of $965.6 million for FY2024, which is 15.80% up from last year.
  • Agios Pharmaceuticals' Current Assets amounted to $965.6 million in FY2024, which was up 15.80% from $833.8 million recorded in FY2023.
  • Over the past 5 years, Agios Pharmaceuticals' Current Assets peaked at $1.1 billion during FY2021, and registered a low of $636.7 million during FY2020.
  • Its 3-year average for Current Assets is $877.4 million, with a median of $833.8 million in 2023.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Current Assets spiked by 67.15% in 2021, and later fell by 21.75% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Current Assets (Yearly) stood at $636.7 million in 2020, then skyrocketed by 67.15% to $1.1 billion in 2021, then fell by 21.75% to $832.8 million in 2022, then climbed by 0.13% to $833.8 million in 2023, then rose by 15.80% to $965.6 million in 2024.